Adds xylazine to the list of controlled substances in New York, except for use in cattle or other nonhuman species approved by the FDA.
New York State Senate bill S04676 amends the public health law to classify xylazine as a controlled substance, with an exception for its use in cattle or other nonhuman species if approved by the FDA. Individuals found in possession, sale, administration, prescription, or distribution of xylazine for human consumption or unauthorized purposes face penalties. The bill aims to regulate the use of xylazine, a potent animal tranquilizer, to prevent its misuse in humans.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.